A new metabolomic signature in type-2 diabetes mellitus and its pathophysiology

PLoS ONE

Volumn 9, Issue 1, 2014, Pages

  Padberg, Inken ^a   Peter, Erik ^a   González Maldonado, Sandra ^a   Witt, Henning ^a   Mueller, Matthias ^b   Weis, Tanja ^b   Bethan, Bianca ^a   Liebenberg, Volker ^a,c   Wiemer, Jan ^a   Katus, Hugo A ^b   Rein, Dietrich ^a   Schatz, Philipp ^a  

^a Metanomics Health GmbH   (Germany)

^b UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^c THERMO FISHER SCIENTIFIC   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

15 HYDROXYICOSATETRAENOIC ACID; ANTIHYPERTENSIVE AGENT; ARACHIDONIC ACID; BRANCHED CHAIN AMINO ACID; DIHOMO GAMMA LINOLENIC ACID; GLUCOSE; GLYOXYLIC ACID; HEXOSAMINE; ICOSANOID; LIPOXYGENASE; PROSTAGLANDIN E2; PROSTAGLANDIN SYNTHASE; THROMBOXANE B2;

ARTICLE; BLOOD ANALYSIS; CONTROLLED STUDY; DIET RESTRICTION; HEART FAILURE; HUMAN; HYPERGLYCEMIA; HYPERTENSION; IMPAIRED GLUCOSE TOLERANCE; METABOLOMICS; NON INSULIN DEPENDENT DIABETES MELLITUS; ORAL GLUCOSE TOLERANCE TEST; PATHOPHYSIOLOGY;

AMINO ACIDS, BRANCHED-CHAIN; ANTIHYPERTENSIVE AGENTS; CASE-CONTROL STUDIES; DIABETES MELLITUS, TYPE 2; EICOSANOIDS; FASTING; GLUCOSE TOLERANCE TEST; GLYOXYLATES; HEXOSAMINES; HUMANS; METABOLOMICS; MODELS, BIOLOGICAL; PREDIABETIC STATE;

EID: 84898406508     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0085082     Document Type: Article

References (24)

1. Ferrannini E, Cushman WC (2012) Diabetes and hypertension: the bad companions. Lancet 380: 601-610. S0140-6736(12)60987-8 [pii];10.1016/S0140- 6736(12)60987-8 [doi].
2. Lindstrom J, Tuomilehto J (2003) The diabetes risk score - A practical tool to predict type 2 diabetes risk. Diabetes Care 26: 725-731. (Pubitemid 36929335)
3. Wang-Sattler R, Yu Z, Herder C, Messias AC, Floegel A, et al. (2012) Novel biomarkers for pre-diabetes identified by metabolomics. Mol Syst Biol 8: 615. msb201243 [pii];10.1038/msb.2012.43 [doi].
4. Wang TJ, Larson MG, Vasan RS, Cheng S, Rhee EP, et al. (2011) Metabolite profiles and the risk of developing diabetes. Nat Med 17: 448-453. nm.2307 [pii];10.1038/nm.2307 [doi].
5. Shaham O, Wei R, Wang TJ, Ricciardi C, Lewis GD, et al. (2008) Metabolic profiling of the human response to a glucose challenge reveals distinct axes of insulin sensitivity. Mol Syst Biol 4. 10.1038/msb.2008.50.
6. American Diabetes Association (2011) Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 34: S62-S69.
7. Gall WE, Beebe K, Lawton KA, Adam KP, Mitchell MW, et al. (2010) alpha-Hydroxybutyrate Is an Early Biomarker of Insulin Resistance and Glucose Intolerance in a Nondiabetic Population. Plos One 5.
8. Dungan KM, Buse JB, Largay J, Kelly MM, Button EA, et al. (2006) 1,5-Anhydroglucitol and Postprandial Hyperglycemia as Measured by Continuous Glucose Monitoring System in Moderately Controlled Patients With Diabetes. Diabetes Care 29: 1214-1219. (Pubitemid 44125912)
9. Issad T, Masson E, Pagesy P (2010) O-GlcNAc modification, insulin signaling and diabetic complications. Diabetes & Metabolism 36: 423-435.
10. Buse MG (2006) Hexosamines, insulin resistance, and the complications of diabetes: current status. American Journal of Physiology-Endocrinology and Metabolism 290: E1-E8.
11. Brownlee M (2005) The pathobiology of diabetic complications: a unifying mechanism. Diabetes5416151625
12. Kim DH, Seok YM, Kim IK, Lee IK, Jeong SY, et al. (2011) Glucosamine increases vascular contraction through activation of RhoA/Rho kinase pathway in isolated rat aorta. Bmb Reports 44: 415-420.
13. Faure P, Tamisier R, Baguet JP, Favier A, Halimi S, et al. (2008) Impairment of serum albumin antioxidant properties in obstructive sleep apnoea syndrome. European Respiratory Journal 31: 1046-1053.
14. Nayak AU, Nevill AM, Bassett P, Singh BM (2013) Association of Glycation Gap With Mortality and Vascular Complications in Diabetes. Diabetes Care.
15. Adedayo A, Olafiranye O, Smith D, Hill A, Zizi F, et al. (2012) Obstructive sleep apnea and dyslipidemia: evidence and underlying mechanism. Sleep Breath.16
16. Sathiyapriya V, Selvaraj N, Nandeesha H, Bobby Z, Agrawal A, et al. (2007) Enhanced Glycation of Hemoglobin and Plasma Proteins Is Associated with Increased Lipid Peroxide Levels in Non-Diabetic Hypertensive Subjects. Arch Med Res 38: 822-826. (Pubitemid 47513278)
17. Knight J, Assimos D, Easter L, Holmes R (2010) Metabolism of Fructose to Oxalate and Glycolate. Hormone and Metabolic Research 42: 868-873.
18. HOLMES RP, ASSIMOS DG (1998) GLYOXYLATE SYNTHESIS, AND ITS MODULATION AND INFLUENCE ON OXALATE SYNTHESIS. J Urol 160: 1617-1624.
19. Barngrover DA, Stevens HC, Dills WL (1981) D-Xylulose-1-Phosphate - Enzymatic Assay and Production in Isolated Rat Hepatocytes. Biochemical and Biophysical Research Communications 102: 75-80. (Pubitemid 12201922)
20. Rodionov RN, Murry DJ, Vaulman SF, Stevens JW, Lentz SR (2010) Human Alanine-Glyoxylate Aminotransferase 2 Lowers Asymmetric Dimethylarginine and Protects from Inhibition of Nitric Oxide Production. Journal of Biological Chemistry 285: 5385-5391.
21. Caplin B, Wang Z, Slaviero A, Tomlinson J, Dowsett L, et al. (2012) Alanine-Glyoxylate Aminotransferase-2 Metabolizes Endogenous Methylarginines, Regulates NO, and Controls Blood Pressure. Arteriosclerosis, Thrombosis, and Vascular Biology.
22. Begum N, Sandu OA, Duddy N (2002) Negative regulation of Rho signaling by insulin and its impact on actin cytoskeleton organization in vascular smooth muscle cells - Role of nitric oxide and cyclic guanosine monophosphate signaling pathways. Diabetes 51: 2256-2263. (Pubitemid 34729033)
23. Vanpraag D, Minkin E, Farber SJ (1986) Inhibition of Eicosanoid Formation by Prazosin in the Rabbit Renal-Cortex. Prostaglandins Leukotrienes and Medicine 24: 227-240. (Pubitemid 16004122)
24. Schror K (1990) Converting Enzyme-Inhibitors and the Interaction Between Kinins and Eicosanoids. Journal of Cardiovascular Pharmacology 15: S60-S68.